Runda Medical(SH:603108) Xin Lang Cai Jing·2026-02-03 05:55Group 1 - The core viewpoint of the news is that RunDa Medical has seen a stock price increase of 5.12%, reaching 16.22 CNY per share, with a trading volume of 284 million CNY and a turnover rate of 2.97%, resulting in a total market capitalization of 9.792 billion CNY [1] - RunDa Medical, established on January 6, 1999, and listed on May 27, 2015, is located in Shanghai and primarily provides in vitro diagnostic products and professional technical support to various medical laboratories through its comprehensive service system [1] - The company's main revenue composition includes reagents and other consumables at 93.50%, instruments at 3.70%, software development and services at 2.67%, and other (supplementary) at 0.14% [1] Group 2 - From the perspective of RunDa Medical's top ten circulating shareholders, Southern Fund's Southern CSI 1000 ETF (512100) reduced its holdings by 48,700 shares in the third quarter, now holding 4.4119 million shares, which accounts for 0.73% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 78.996 billion CNY, and has achieved a year-to-date return of 4.98%, ranking 1606 out of 5562 in its category [2] - The fund manager, Cui Lei, has a cumulative tenure of 7 years and 90 days, with the fund's total asset scale at 137.02 billion CNY, achieving the best return of 279.97% and the worst return of -15.93% during the tenure [2]